Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Quantum BioPharma Ltd (QNTM)

NASDAQ
Currency in USD
4.2300
-0.0600(-1.40%)
Closed
After Hours
4.1500-0.0800(-1.8913%)

QNTM Income Statement

Advanced Income Statement
Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa---
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa---
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa---
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa---
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa---
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa---
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa42.6337.1625.48
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-42.63-37.16-25.48
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-12.22%+12.82%+31.45%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-0.090.431.04
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+70.85%+602.13%+140.95%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-0.09-0.07-0
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa00.51.04
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa0.860.710.28
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-41.86-36.03-24.15
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa---
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa0.060.160.51
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-42.88-36.18-24.15
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-18.38%+15.62%+33.26%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa---
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-44.58-31.98-24.15
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa--0.43
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-44.58-31.98-23.71
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-10.12%+28.25%+25.87%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa---
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-42.88-36.18-23.71
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-79.75-60.72-38.93
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+59.2%+23.87%+35.88%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-79.75-60.72-38.93
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+59.2%+23.87%+35.88%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa0.680.810.81
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa0.680.810.81
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa---
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa---
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-37.52-31.02-22.16
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-13.61%+17.32%+28.58%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa---
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa<